Rapid Therapeutic Science Laboratories, Inc. (RTSL)
OTCMKTS: RTSL · Delayed Price · USD
0.0015
-0.0007 (-31.82%)
Aug 30, 2024, 2:24 PM EDT - Market closed

RTSL Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM 2022 2021 2020 2020 2019 2018 - 2014
Period Ending
Jun '23 Dec '22 Dec '21 Dec '20 Mar '20 Mar '19 2018 - 2014
Revenue
--00.140.01-
Upgrade
Revenue Growth (YoY)
---99.62%1432.50%--
Upgrade
Cost of Revenue
--00.030.01-
Upgrade
Gross Profit
--00.110-
Upgrade
Selling, General & Admin
0.521.242.142.250.40.17
Upgrade
Operating Expenses
0.471.262.182.350.430.17
Upgrade
Operating Income
-0.47-1.26-2.18-2.24-0.43-0.17
Upgrade
Interest Expense
-0.59-1.9-1.32-0.12-0.19-0.18
Upgrade
Other Non Operating Income (Expenses)
1.111.360.63---
Upgrade
EBT Excluding Unusual Items
0.06-1.79-2.87-2.36-0.62-0.35
Upgrade
Other Unusual Items
-----0
Upgrade
Pretax Income
0.06-1.79-2.87-2.36-0.62-0.35
Upgrade
Net Income
0.06-1.79-2.87-2.36-0.62-0.35
Upgrade
Net Income to Common
0.06-1.79-2.87-2.36-0.62-0.35
Upgrade
Shares Outstanding (Basic)
888720
Upgrade
Shares Outstanding (Diluted)
888720
Upgrade
Shares Change (YoY)
2.64%1.54%14.77%176.87%4885.43%-51.18%
Upgrade
EPS (Basic)
0.01-0.23-0.38-0.36-0.26-7.24
Upgrade
EPS (Diluted)
0.01-0.23-0.38-0.36-0.26-7.24
Upgrade
Free Cash Flow
-0.25-1.19-2.5-1.99-0.19-0.11
Upgrade
Free Cash Flow Per Share
-0.03-0.15-0.33-0.30-0.08-2.21
Upgrade
Gross Margin
--62.55%81.04%21.71%-
Upgrade
Operating Margin
---407471.54%-1600.35%-4737.97%-
Upgrade
Profit Margin
---537056.74%-1687.39%-6834.27%-
Upgrade
Free Cash Flow Margin
---468476.03%-1417.65%-2084.95%-
Upgrade
EBITDA
-0.44-1.24-2.14-2.13-0.4-0.15
Upgrade
D&A For EBITDA
0.020.020.030.110.040.02
Upgrade
EBIT
-0.47-1.26-2.18-2.24-0.43-0.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.